Overview

Efficacy Study of Lisdexamfetamine to Treat Binge Eating Disorder

Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The specific aim of this study is to examine the efficacy and safety of lisdexamfetamine compared with placebo in outpatients with binge eating disorder
Phase:
Phase 3
Details
Lead Sponsor:
Lindner Center of HOPE
Collaborators:
Shire
University of Cincinnati
Treatments:
Lisdexamfetamine Dimesylate